Journal of Multiple Sclerosis and Neuroimmunology

Review Article

December 31, 2025

Cognitive Dysfunction and Assessment in Multiple Sclerosis

Eun Oh, Seong-il Oh

J Mult Scler Neuroimmunol. 2025;16(2):35-44.

Cognitive impairment is a common and disabling feature of multiple sclerosis (MS), affecting up to 65% of patients. It primarily manifests as deficits in processing speed, memory, executive function, and...

Review Article

December 31, 2025

Disability Measurement in Multiple Sclerosis: Beyond EDSS

You-Ri Kang, Tai-Seung Nam

J Mult Scler Neuroimmunol. 2025;16(2):45-52.

Multiple sclerosis (MS) is a chronic inflammatory disorder of the central nervous system in which relapses and neurodegeneration lead to cumulative neurological decline. Historically, therapeutic development in MS has focused...

Original Article

December 31, 2025

Real-World Epidemiology of Multiple Sclerosis in Korea: Insights from a 2025 Nationwide Hospital-Based Multicenter Study

Sooyoung Kim, Ho Jin Kim, Jae-Won Hyun, et al.

J Mult Scler Neuroimmunol. 2025;16(2):53-59.

Background: A hospital-based survey conducted in 2023 provided initial insight into the realworld landscape of multiple sclerosis (MS) care. Based on 2023 survey, the present study aims to offer an...

Case Report

December 31, 2025

Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder Triggered by Herpes Zoster: A Case Report and Literature Review

Daecheol Moon, Dong Kyu Kim, Seong-il Oh

J Mult Scler Neuroimmunol. 2025;16(2):60-65.

We report the case of a 70-year-old female who developed acute transverse myelitis 1 month after herpes zoster infection and was diagnosed with aquaporin-4 (AQP4) antibody-positive neuromyelitis optica spectrum disorder....

Current Issue: Volume 16(2); Dec 2025

This archive contains links to the full-text of all issues of J Mult Scler Neuroimmunol.

Current issue

Volume 16(2); December

All issues

Vol. 16
2025

v.16(1)

v.16(2)

Vol. 15
2024

v.15(1)

v.15(2)

Vol. 14
2023

v.14(1)

v.14(2)

Vol. 13
2022

v.13(1)

v.13(2)

Vol. 12
2021

v.12(1)

v.12(2)

Vol. 11
2020

v.11(1)

v.11(2)

Journal of Multiple Sclerosis2010 (v1 n1)

Vol. 10
2019

v.10(1)

v.10(2)

Vol. 9
2018

v.9(1)

v.9(2)

Vol. 8
2017

v.8(1)

v.8(2)

Vol. 7
2016

v.7(1)

v.7(2)

Vol. 6
2015

v.6(1)

v.6(2)

Vol. 5
2014

v.5(1)

v.5(2)

Vol. 4
2013

v.4(1)

v.4(2)

Vol. 3
2012

v.3(1)

v.3(2)

Vol. 2
2011

v.2(1)

v.2(2)

Vol. 1
2010

v.1(1)

v.1(2)

Volume 16, No. 2

Journal of Multiple
Sclerosis and
Neuroimmunology

Print ISSN: 2733-8290
Online ISSN: 2951-2972

MOST VIEWED MOST CITED

3,378	Autoimmune Nodopathy: When to Suspect and How to Treat?
3,029	National Consensus Guidance for Management of Refractory Myasthenia Gravis
2,117	Monoclonal Antibody Treatment for Relapse Prevention in Neuromyelitis Optica Spectrum Disorder
1,963	Clinicoradiological Factors for Predicting and Monitoring the Progression of Multiple Sclerosis
1,529	Severe Neutropenia Following Rituximab Treatment in Patients with Multiple Sclerosis

Cited By 1	National Consensus Guidance for Management of Refractory Myasthenia Gravis
Cited By 1	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as a Diffuse Pachymeningitis

Editorial Office: Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine 102, Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-3153 E-mail: jmsni@koreams.org

Copyright © 2026 by Korean Society of Neuroimmunology.